Romet-lemonne Jean-loup

Biography

Jean-Loup Romet-Lemonne, MD has been President of VitamFero since June 2, 2017, having been an independent director of the company since November 2012. He has 29 years of experience in the biotechnology industry. Founder of IDM SA became IDM Pharma (NASDAQ as IDMI), he was the president and CEO for 17 years. IDM Pharma, a company specializing in cancer immunotherapy, was acquired in 2009 by Takeda Oncology. Since January 2014 he has been working as an advisor to the Director General of the Institut Pasteur for international development issues. Former Vice President of France Biotech, he has been involved for the last ten years in the development of innovative French biotechnology companies, and is a member of the boards of Antabio and PEP-Therapy. The doctor. Romet Lemonne is the author of some fifty international scientific publications, Doctor, former Lecturer at the Faculty of Medicine of Tours having followed a business training at HEC-Management and at the University of Standford (California), Dr. Jean -Loup Romet-Lemonne spent 5 years at the Harvard School of Public Health in Boston as a researcher. He lives and works in New York.

Research Interest

Bioinformatics & Systems Biology